Floris F. Van Den Brand

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis.

Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: October 07, 2024

Reply: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome-First report of the IAIHG retrospective registry.

Reply: Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome-First report of the IAIHG retrospective registry.

Journal: Hepatology (Baltimore, Md.)

Published: October 26, 2023

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.

Journal: Journal of hepatology

Published: July 19, 2023

Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.

Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.

Journal: Hepatology (Baltimore, Md.)

Published: February 05, 2023

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.

Journal: Journal of hepatology

Published: February 01, 2023

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.

Journal: Trials

Published: June 01, 2022

Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study.

Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study.

Journal: European journal of internal medicine

Published: September 23, 2020

Adverse events related to low dose corticosteroids in autoimmune hepatitis.

Adverse events related to low dose corticosteroids in autoimmune hepatitis.

Journal: Alimentary pharmacology & therapeutics

Published: June 26, 2019

Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis.

Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 01, 2018

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

Journal: Alimentary pharmacology & therapeutics

Published: April 12, 2018

Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.

Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: February 14, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026